Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 21 04:00PM ET
22.97
Dollar change
+0.04
Percentage change
0.16
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week0.74%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings31 Perf Month-11.10%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM50.14M Perf Quarter-7.52%
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M-3.82% 52W Range21.91 - 27.76 Perf YTD-1.81%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M5.66% 52W High-17.26% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD5.72% 52W Low4.83% ATR (14)0.50
Expense0.54% Structure Type Region Flows% 1Y RSI (14)42.83 Volatility1.17% 1.77%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.80 Prev Close22.93
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.86K Price22.97
SMA20-1.24% SMA50-6.55% SMA200-7.67% Trades Volume3,096 Change0.16%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.